Some antidepressants are linked to a slight increased risk of bleeding stroke, according to a new analysis.
Researchers looked at 16 published studies that included more than 500,000 people.
They focused on the popular antidepressants known as SSRIs (selective serotonin reuptake inhibitors). SSRIs include Celexa (citalopram), Lexapro (escitalopram), Paxil (paroxetine), Prozac (fluoxetine), Viibryd (vilazodone), and Zoloft (sertraline).
For most people, though, the risk of stroke linked with these drugs is low, says researcher Daniel G. Hackam, MD, PhD, associate professor of medicine at Western University in London, Ontario, Canada.
Overall, he says, "the additional bleeding risk is 1 per 10,000 people treated with SSRIs for one year."
For those who already have risk factors for bleeding stroke, however, the risk is higher, he says.
The studies evaluated found a link, not cause and effect. The new analysis is published online in Neurology.
Stroke strikes about 795,000 Americans each year, according to the American Stroke Association.
Antidepressants and Stroke Risk: Study Details
Hackam's team combed the medical literature to find studies on SSRIs and brain hemorrhage.
The drugs are known to raise the risk of gastrointestinal bleeding. Studies on their link with brain bleeding have mixed findings, Hackam says.
To be included in the new analysis, studies had to include a comparison group that wasn't on SSRIs and meet other scientific criteria.
Hackam found that people taking SSRIs were about 40% or 50% more likely than those not on the drugs to have strokes known as intracranial hemorrhages or intracerebral hemorrhages.
These types of strokes are rare, Hackam says. Although a 50% increase sounds high, it does not translate to a high actual or "absolute" risk, he says.
About 25 of these types of strokes occur per 100,000 people per year, he says. Based on his findings, one more would occur for every 10,000 people on the drugs for a year, he estimates.
The risk of stroke found for those taking SSRIs who already had risk factors for strokes, such as being on anticoagulants or blood thinners, was higher, the researchers found.
Those on SSRIs who are already at risk for stroke should talk to their doctor, Hackam says. "If you are already taking blood thinners or antiplatelet drugs, you should talk to your doctor about which is the most appropriate class of antidepressants you should take."
SSRIs slow down the rate of blood clot formation. This is thought to explain the link between antidepressants and hemorrhagic stroke risk.
Antidepressants and Stroke Risk: Perspectives
With so many people on SSRIs, the new analysis is important, says Jordan Smoller, MD, ScD, associate professor of psychiatry at Harvard Medical School. He has also researched the link.
However, he points out some important caveats. All the studies are observational, he says. "So they can tell us there is a correlation, but that doesn't necessarily mean that there is a causal connection."
The individual risk for bleeding is still low, he says.
"And, we should remember that the conditions people take SSRIs for -- depression and anxiety -- have their own risks in terms of adverse health outcomes, suffering, disability, and even suicide," Smoller says. "So it's not a matter of risk versus no risk."
People should also explore non-medication therapies for depression, he says. Among the options are talk therapy.
WebMD contacted SSRI manufacturers for comment on the study. MacKay Jimeson, a spokesperson for Pfizer, which makes Zoloft, declined to comment. Spokespeople for Eli Lilly, which makes Prozac, did not comment. Representatives from Forest Laboratories, which makes Celexa, Lexapro, and Viibryd, also declined comment.
To comment, the following rules must be followed:
Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.
Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Questions may be sent to firstname.lastname@example.org. Please provide detailed information.